🚀 VC round data is live in beta, check it out!
- Public Comps
- Colgate-Palmolive
Colgate-Palmolive Valuation Multiples
Discover revenue and EBITDA valuation multiples for Colgate-Palmolive and similar public comparables like Hindustan Unilever, Galderma, Bayer, EssilorLuxottica and more.
Colgate-Palmolive Overview
About Colgate-Palmolive
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Founded
1923
HQ

Employees
33.6K
Website
Sectors
Financials (LTM)
EV
$77B
Valuation Multiples
Start free trialColgate-Palmolive Financials
Colgate-Palmolive reported last 12-month revenue of $21B and EBITDA of $5B.
In the same LTM period, Colgate-Palmolive generated $12B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Colgate-Palmolive P&L
In the most recent fiscal year, Colgate-Palmolive reported revenue of $20B and EBITDA of $5B.
Colgate-Palmolive is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 24%, and net margin of 15%.
Financial data powered by Morningstar, Inc.
Colgate-Palmolive Stock Performance
Colgate-Palmolive has current market cap of $70B, and enterprise value of $77B.
Market Cap Evolution
Colgate-Palmolive's stock price is $87.26.
Colgate-Palmolive share price increased by 2.2% in the last 30 days, and decreased by 6.1% in the last year.
Colgate-Palmolive has an EPS (earnings per share) of $3.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $77B | $70B | 0.0% | 2.2% | -12.0% | -6.1% | $3.73 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialColgate-Palmolive Valuation Multiples
Colgate-Palmolive trades at 3.7x EV/Revenue multiple, and 15.4x EV/EBITDA.
EV / Revenue (LTM)
Colgate-Palmolive Financial Valuation Multiples
As of May 3, 2026, Colgate-Palmolive has market cap of $70B and EV of $77B.
Colgate-Palmolive has a P/E ratio of 23.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Colgate-Palmolive Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Colgate-Palmolive Margins & Growth Rates
Colgate-Palmolive grew revenue by 5% and EBITDA by 2% in the last fiscal year.
In the most recent fiscal year, Colgate-Palmolive reported gross margin of 60%, EBITDA margin of 24%, and net margin of 15%.
Colgate-Palmolive Margins
Colgate-Palmolive Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive Operational KPIs
Colgate-Palmolive's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Colgate-Palmolive's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive Competitors
Colgate-Palmolive competitors include Hindustan Unilever, Galderma, Bayer, EssilorLuxottica, Haleon, Reckitt, Kenvue, Kimberly-Clark, Estee Lauder and Unilever.
Most Colgate-Palmolive public comparables operate across Health & Beauty and Home Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 8.4x | 8.2x | 32.2x | 34.8x | |||
| 9.8x | 9.2x | 42.2x | 37.9x | |||
| 1.4x | 1.5x | 6.9x | 6.9x | |||
| 3.3x | 3.2x | 13.6x | 13.3x | |||
| 3.4x | 3.4x | 13.3x | 13.1x | |||
| 2.6x | 2.7x | 7.7x | 9.3x | |||
| 2.7x | 2.7x | 12.0x | 11.8x | |||
| 2.4x | 2.3x | 11.0x | 10.6x | |||
This data is available for Pro users. Sign up to see all Colgate-Palmolive competitors and their valuation data. Start Free Trial | ||||||
Colgate-Palmolive M&A Activity
Colgate-Palmolive has acquired 7 companies to date.
Last acquisition by Colgate-Palmolive was on February 18th 2025. Colgate-Palmolive acquired Prime100 for $500M (EV/Revenue multiple of ).
Latest Acquisitions by Colgate-Palmolive
| Description | Prime100 is an Australian pet food manufacturer producing premium dry kibble and wet foods for dogs and cats. Headquartered in Melbourne, Victoria, it formulates products like Prime100 Salmon & Sardine for skin health and Prime100 Joint Care with glucosamine. The company sources ingredients from local suppliers and conducts feeding trials compliant with AAFCO standards. Distributed through pet specialty stores and veterinarians across Australia and New Zealand, Prime100 emphasizes hypoallergenic recipes free from artificial preservatives. | Red Collar Pet Foods is a contract manufacturer of private-label pet food and treats. Ohio-based with facilities exceeding 500,000 square feet, it produces dry kibble, wet foods, and chews for brands sold at Petco and independent retailers, adhering to AAFCO standards. | Hello Products is a Los Angeles-based oral care brand offering naturally sourced toothpastes, mouthwashes, and floss in flavors like activated charcoal and sea salt. Vegan and cruelty-free, products avoid triclosan and artificial sweeteners, manufactured in the US. Acquired by Colgate-Palmolive in 2020, Hello distributes through Walmart and Amazon nationwide. | — | |
| HQ Country | |||||
| HQ City | Melbourne | Nashville, TN | Montclair, NJ | — | |
| Deal Date | 18 Feb 2025 | 1 Aug 2022 | 23 Jan 2020 | 11 Jul 2019 | |
| Valuation | $500M | $700M | $351M | $2B | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Colgate-Palmolive acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Colgate-Palmolive Investment Activity
Colgate-Palmolive has invested in 2 companies to date.
Latest investment by Colgate-Palmolive was on December 26th 2019. Colgate-Palmolive invested in Bombay Shaving Company in their $6M Series B round (EV/Revenue multiple of ).
Latest Investments by Colgate-Palmolive
| Description | Bombay Shaving Company is a New Delhi-based direct-to-consumer brand offering men's grooming essentials including razor blades, beard oils, face washes, and body lotions sold via its website and platforms like Amazon India. Founded in 2016, it disrupted the market with subscription models for razors and expanded to over 100 products by 2023. The company operates manufacturing facilities in Gurugram and Bhiwadi, reaching customers through 5000 retail outlets nationwide. | HUBBLE is a New York-based direct-to-consumer retailer of contact lenses, eyeglasses, and sunglasses. It offers daily, bi-weekly, and monthly disposable lenses from brands like Acuvue and Dailies, plus affordable frames in styles ranging from classic to bold. Customers subscribe for automatic deliveries, with free shipping across the United States and virtual try-on tools. The company expanded from contacts to include prescription glasses and non-prescription sunglasses since launching in 2016. |
| HQ Country | ||
| HQ City | New Delhi | New York City, NY |
| Deal Date | 26 Dec 2019 | 2 Jul 2018 |
| Round | Series B | Series B |
| Raised | $6M | $45M |
| Investors | Colgate-Palmolive; Sixth Sense Ventures | Bellco Capital; Colgate-Palmolive; FirstMark; Founders Fund; Gaingels; Greycroft; Two River; Wildcat Capital Management |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Colgate-Palmolive investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Colgate-Palmolive
| When was Colgate-Palmolive founded? | Colgate-Palmolive was founded in 1923. |
| Where is Colgate-Palmolive headquartered? | Colgate-Palmolive is headquartered in United States. |
| How many employees does Colgate-Palmolive have? | As of today, Colgate-Palmolive has over 33K employees. |
| Who is the CEO of Colgate-Palmolive? | Colgate-Palmolive's CEO is Noel R. Wallace. |
| Is Colgate-Palmolive publicly listed? | Yes, Colgate-Palmolive is a public company listed on NYSE. |
| What is the stock symbol of Colgate-Palmolive? | Colgate-Palmolive trades under CL ticker. |
| When did Colgate-Palmolive go public? | Colgate-Palmolive went public in 1951. |
| Who are competitors of Colgate-Palmolive? | Colgate-Palmolive main competitors include Hindustan Unilever, Galderma, Bayer, EssilorLuxottica, Haleon, Reckitt, Kenvue, Kimberly-Clark, Estee Lauder, Unilever. |
| What is the current market cap of Colgate-Palmolive? | Colgate-Palmolive's current market cap is $70B. |
| What is the current revenue of Colgate-Palmolive? | Colgate-Palmolive's last 12 months revenue is $21B. |
| What is the current revenue growth of Colgate-Palmolive? | Colgate-Palmolive revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Colgate-Palmolive? | Current revenue multiple of Colgate-Palmolive is 3.7x. |
| Is Colgate-Palmolive profitable? | Yes, Colgate-Palmolive is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Colgate-Palmolive? | Colgate-Palmolive's last 12 months EBITDA is $5B. |
| What is Colgate-Palmolive's EBITDA margin? | Colgate-Palmolive's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Colgate-Palmolive? | Current EBITDA multiple of Colgate-Palmolive is 15.4x. |
| What is the current FCF of Colgate-Palmolive? | Colgate-Palmolive's last 12 months FCF is $3B. |
| What is Colgate-Palmolive's FCF margin? | Colgate-Palmolive's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Colgate-Palmolive? | Current FCF multiple of Colgate-Palmolive is 22.4x. |
| How many companies Colgate-Palmolive has acquired to date? | As of May 2026, Colgate-Palmolive has acquired 7 companies. |
| What was the largest acquisition by Colgate-Palmolive? | $2B acquisition of Filorga Cosmétiques (skincare unit) on 11th July 2019 was the largest M&A Colgate-Palmolive has done to date. |
| What companies Colgate-Palmolive acquired? | Colgate-Palmolive acquired Filorga Cosmétiques (skincare unit), Red Collar Pet Foods, Prime100, Hello Products, EltaMD, PCA Skin, and Laser Brands Toothpaste. |
| In how many companies Colgate-Palmolive has invested to date? | As of May 2026, Colgate-Palmolive has invested in 2 companies. |
| What was the last Colgate-Palmolive investment? | On 26th December 2019 Colgate-Palmolive invested in Bombay Shaving Company, participating in a $6M Series B round, alongside Sixth Sense Ventures. |
| In what companies Colgate-Palmolive invested in? | Colgate-Palmolive invested in HUBBLE and Bombay Shaving Company. |
See public comps similar to Colgate-Palmolive
Lists including Colgate-Palmolive
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



